Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Infect. 1983 Jul;7 Suppl 1:81-4.

The cost-effectiveness of hepatitis B vaccine.

Abstract

We evaluated the cost-effectiveness of different strategies for use of hepatitis B vaccine. For populations with high prevalences of immunity and high attack rates, screening for prior immunity and vaccinating susceptibles is the lowest cost strategy. For populations with low prevalences of immunity but with high attack rates, vaccination without screening is most cost-saving. For populations with low prevalences of immunity and low attack rates, a non-vaccination policy is least costly. Vaccination will be cost-saving for populations with annual attack rates of five per cent, if direct medical costs only are considered or, for populations with annual attack rates on the order of one per cent, if indirect medical costs are included.

PMID:
6425416
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk